Spermatech initiates cooperation with Drug Discovery Laboratory AS

Published 25.10.14 Oslo

Oslo, Norway – Spermatech AS has entered a drug optimization and development program with drug discovery company Drug Discovery Laboratory AS. The program will optimize the potency of identified hit compounds inhibiting target proteins in sperm cells involved in sperm motility and fertilization. DDL will also aid in the improvement of pharmacokinetics.